Eli Lilly’s momentum stems from blockbuster GLP-1 therapies (Mounjaro, Zepbound), fuelling revenue growth, long-term margin expansion, and an ethos driving America’s health focus across ...

Eli Lilly has begun the week with a bang. Early Monday morning, AdvanCell and OliX Pharmaceuticals put out news that the Big Pharma is coughing up cash to work with them on radiopharmaceuticals ...

and the lead detective on the case recently revealed how authorities nabbed the killer and discovered an eerie obsession. Kevin Jiang, a 26-year-old graduate student at Yale’s School of the ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks. Ken Fisher is the founder and executive chairman of Fisher Asset Management ...

Eli Lilly & Co. tapped the US investment-grade bond market on Monday to help finance its roughly $2.5 billion purchase of a cancer drug from Scorpion Therapeutics Inc. The pharmaceutical company ...

Eli Lilly and Company (NYSE: LLY) announced results from the VIVID-2 open-label extension study, which showed the majority of patients with moderately to severely active Crohn's disease receiving ...

NOW OPEN: 200 Charter Memberships to Benzinga Trade Alerts On Friday, Eli Lilly And Cao LLY announced the results from the VIVID-2 open-label extension study of Omvoh (mirikizumab-mrkz).

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks. In an era where financial literacy is increasingly recognized as a crucial ...

But Brendan, who still suffers "terrible pain" from the wounds to both his legs, said: "Life’s not been kind to me but it was much crueler to little Fred, who lost his life, and his family.

Pfizer and Eli Lilly have produced more phase III data that appear to back their non-opioid painkiller tanezumab, although there were mixed results at a lower dose in the osteoarthritis pain trial.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...